Related Experiment Video
Updated: Mar 6, 2026
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Molecular mechanisms and therapeutic targets in pediatric brain tumors
Kun-Wei Liu1, Kristian W Pajtler2,3,4, Barbara C Worst2,3,4
1Tumor Initiation and Maintenance Program, National Cancer Institute-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Abstract:
Brain tumors are among the leading causes of cancer-related deaths in children. Although surgery, aggressive radiation, and chemotherapy have improved outcomes, many patients still die of their disease. Moreover, those who survive often suffer devastating long-term side effects from the therapies. A greater understanding of the molecular underpinnings of these diseases will drive the development of new therapeutic approaches. Advances in genomics and epigenomics have provided unprecedented insight into the molecular diversity of these diseases and, in several cases, have revealed key genes and signaling pathways that drive tumor growth. These not only serve as potential therapeutic targets but also have facilitated the creation of animal models that faithfully recapitulate the human disease for preclinical studies. In this Review, we discuss recent progress in understanding the molecular basis of the three most common malignant pediatric brain tumors-medulloblastoma, ependymoma, and high-grade glioma-and the implications for development of safer and more effective therapies.
Insights
Understanding the molecular basis of pediatric brain tumors like medulloblastoma, ependymoma, and high-grade glioma is crucial. This knowledge aids in developing targeted therapies and improving outcomes for children with these devastating diseases.
Area of Science:
- Pediatric oncology
- Molecular biology
- Genomics and epigenomics
Background:
- Pediatric brain tumors are a major cause of cancer-related mortality in children.
- Current treatments (surgery, radiation, chemotherapy) have limitations and cause severe side effects.
- A deeper understanding of molecular mechanisms is needed for novel therapeutic strategies.
Purpose of the Study:
- To review recent advancements in understanding the molecular basis of common malignant pediatric brain tumors.
- To highlight the implications of these findings for developing improved and safer therapies.
- To discuss the role of genomics and epigenomics in revealing tumor diversity and targets.
Main Methods:
- Review of current scientific literature on pediatric brain tumors.
- Analysis of genomic and epigenomic data.
- Discussion of therapeutic targets and preclinical models.
Main Results:
- Genomic and epigenomic studies have illuminated the molecular diversity of pediatric brain tumors.
- Key genes and signaling pathways driving tumor growth have been identified.
- These discoveries facilitate the development of targeted therapies and accurate animal models.
Conclusions:
- Advances in molecular understanding are paving the way for more effective and less toxic treatments for pediatric brain tumors.
- Targeted therapies based on molecular insights offer hope for improved patient outcomes.
- Further research into the molecular underpinnings is essential for continued progress in pediatric neuro-oncology.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism